Free Trial

Seres Therapeutics (MCRB) Short Interest Ratio & Short Volume

$0.92
-0.01 (-0.84%)
(As of 05:27 PM ET)

Seres Therapeutics Short Interest Data

Current Short Interest
22,740,000 shares
Previous Short Interest
21,460,000 shares
Change Vs. Previous Month
+5.96%
Dollar Volume Sold Short
$21.78 million
Short Interest Ratio
4.7 Days to Cover
Last Record Date
May 15, 2024
Outstanding Shares
151,450,000 shares
Percentage of Shares Shorted
15.01%
Today's Trading Volume
988,685 shares
Average Trading Volume
4,751,031 shares
Today's Volume Vs. Average
21%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Seres Therapeutics ?

Sign up to receive the latest short interest report for Seres Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

MCRB Short Interest Over Time

MCRB Days to Cover Over Time

MCRB Percentage of Float Shorted Over Time

Seres Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
5/15/202422,740,000 shares $21.78 million +6.0%N/A4.7 $0.96
4/30/202421,460,000 shares $21.26 million +21.7%N/A4.6 $0.99
4/15/202417,630,000 shares $10.89 million -6.2%N/A4.4 $0.62
3/31/202418,800,000 shares $14.55 million +2.2%N/A4 $0.77
3/15/202418,400,000 shares $14.46 million +14.3%N/A3.9 $0.79
2/29/202416,100,000 shares $18.35 million +3.3%N/A3.3 $1.14
2/15/202415,590,000 shares $17.46 million No ChangeN/A3.5 $1.12
1/31/202415,590,000 shares $17.62 million -11.2%N/A3.4 $1.13
1/15/202417,550,000 shares $21.06 million +7.8%N/A3.3 $1.20
12/31/202316,280,000 shares $22.79 million -21.8%N/A3.3 $1.40
12/15/202320,810,000 shares $20.66 million -0.7%N/A5 $0.99
11/30/202320,950,000 shares $21.79 million -10.4%N/A6 $1.04
11/15/202323,370,000 shares $28.04 million +1.2%N/A6.8 $1.20
10/31/202323,100,000 shares $35.34 million +1.1%N/A7.3 $1.53
10/15/202322,850,000 shares $34.28 million +7.9%N/A9.3 $1.50
9/30/202321,170,000 shares $50.38 million +3.8%N/A10 $2.38
9/15/202320,400,000 shares $58.34 million +0.8%N/A9.6 $2.86
8/31/202320,230,000 shares $69.79 million -13.4%N/A8.5 $3.45
8/15/202323,350,000 shares $87.56 million +3.6%N/A9.3 $3.75
7/31/202322,550,000 shares $108.47 million +1.7%N/A8.5 $4.81
7/15/202322,180,000 shares $100.25 million -2.9%N/A6.4 $4.52
6/30/202322,830,000 shares $109.36 million +25.0%N/A6.3 $4.79
6/15/202318,260,000 shares $104.45 million +17.7%N/A5.2 $5.72
5/31/202315,520,000 shares $76.82 million +3.4%N/A5.1 $4.95
5/15/202315,010,000 shares $80.00 million +23.2%N/A5.4 $5.33
4/30/202312,180,000 shares $59.38 million +36.1%N/A4.9 $4.88
4/15/20238,950,000 shares $52.45 million +3.4%N/A6.2 $5.86
3/31/20238,660,000 shares $49.10 million -7.0%N/A8.4 $5.67
3/15/20239,310,000 shares $54.00 million +19.1%N/A10.5 $5.80
2/28/20237,820,000 shares $39.49 million +8.9%N/A9.9 $5.05
2/15/20237,180,000 shares $36.83 million +9.6%N/A9.9 $5.13
1/31/20236,550,000 shares $35.83 million -0.3%N/A8.9 $5.47
1/15/20236,570,000 shares $36.00 million -3.5%N/A8.2 $5.48
12/30/20226,810,000 shares $38.14 million +43.7%N/A8.5 $5.60
12/15/20224,740,000 shares $27.68 million +11.3%N/A5.7 $5.84
11/30/20224,260,000 shares $27.69 million -1.6%N/A4.4 $6.50
11/15/20224,330,000 shares $30.92 million -9.2%N/A4.4 $7.14
10/31/20224,770,000 shares $42.26 million -3.4%N/A4.8 $8.86
10/15/20224,940,000 shares $33.94 million +0.2%N/A4.9 $6.87
9/30/20224,930,000 shares $31.65 million +45.9%N/A4.7 $6.42
🚀 Tap into this explosive trade opportunity asap (Ad)

I learned about these explosive stocks during my two decades on Wall Street… And used them to help grow my old hedge fund from just a few million to over $700 million dollars*. So it’s safe to say… these bad boys work. What’s the secret behind these special trades? Well, right now, I’m going public with the unique strategy behind these “Calendar Stocks”…

Go here to see how you can exploit my next “Calendar Stock”.
9/15/20223,380,000 shares $24.23 million -1.2%N/A3 $7.17
8/31/20223,420,000 shares $17.58 million +5.2%N/A3 $5.14
8/15/20223,250,000 shares $18.49 million -12.6%3.8%2.8 $5.69
7/31/20223,720,000 shares $15.29 million +4.8%4.6%3 $4.11
7/15/20223,550,000 shares $12.82 million -5.6%4.4%3.1 $3.61
6/30/20223,760,000 shares $12.90 million -25.0%4.6%3.5 $3.43
6/15/20225,010,000 shares $14.13 million +5.7%7.2%5.1 $2.82
5/31/20224,740,000 shares $14.69 million -5.4%6.8%5.6 $3.10
5/15/20225,010,000 shares $18.99 million +0.4%7.2%6.5 $3.79
4/30/20224,990,000 shares $23.60 million +8.2%7.2%6.7 $4.73
4/15/20224,610,000 shares $28.03 million -0.4%6.6%6.1 $6.08
3/31/20224,630,000 shares $32.97 million -14.9%6.7%5.8 $7.12
3/15/20225,440,000 shares $37.37 million -0.4%7.8%6.2 $6.87
2/28/20225,460,000 shares $43.68 million -0.2%7.8%4.3 $8.00
2/15/20225,470,000 shares $46.17 million -1.1%7.9%3.6 $8.44
1/31/20225,530,000 shares $46.12 million -14.8%8.0%3 $8.34
1/15/20226,490,000 shares $52.18 million +9.8%9.3%3.5 $8.04
12/31/20215,910,000 shares $49.23 million -34.3%8.5%3.2 $8.33
12/15/20218,990,000 shares $78.48 million +7.8%12.9%4.7 $8.73
11/30/20218,340,000 shares $89.74 million -6.2%12.0%4.3 $10.76
11/15/20218,890,000 shares $69.43 million +2.0%12.8%4.8 $7.81
10/29/20218,720,000 shares $53.02 million +7.0%12.6%5.5 $6.08
10/15/20218,150,000 shares $51.43 million -10.4%11.8%4.7 $6.31
9/30/20219,100,000 shares $63.34 million +70.1%13.1%4.4 $6.96
9/15/20215,350,000 shares $33.97 million -15.9%7.7%2.5 $6.35
8/31/20216,360,000 shares $40.77 million -9.0%9.2%3.6 $6.41
8/13/20216,990,000 shares $46.48 million +6.1%10.2%4.7 $6.65
7/30/20216,590,000 shares $46.79 million +6.6%9.6%4.5 $7.10
7/15/20216,180,000 shares $125.27 million -2.1%9.0%5.1 $20.27
6/30/20216,310,000 shares $150.49 million -7.5%9.2%7.8 $23.85
6/15/20216,820,000 shares $136.81 million -1.6%9.9%8.7 $20.06
5/28/20216,930,000 shares $146.29 million -2.5%10.1%8.8 $21.11
5/14/20217,110,000 shares $146.89 million -9.5%10.3%7.7 $20.66
4/30/20217,860,000 shares $166.47 million -1.0%11.4%8.1 $21.18
4/15/20217,940,000 shares $163.96 million +1.2%11.6%8.1 $20.65
3/31/20217,850,000 shares $152.53 million +8.6%11.5%7.4 $19.43
3/15/20217,230,000 shares $154.51 million +10.2%10.6%6.2 $21.37
2/26/20216,560,000 shares $123.26 million +10.1%9.6%5.8 $18.79
2/12/20215,960,000 shares $155.32 million -14.2%8.7%5.5 $26.06
1/29/20216,950,000 shares $166.17 million -5.2%10.2%6.6 $23.91
1/15/20217,330,000 shares $195.78 million +3.4%10.8%7.3 $26.71
12/31/20207,090,000 shares $186.11 million +56.2%10.4%7.6 $26.25
12/15/20204,540,000 shares $112.64 million -6.8%6.7%5.3 $24.81
11/30/20204,870,000 shares $141.28 million -3.9%7.3%6.4 $29.01
11/15/20205,070,000 shares $174.71 million +6.5%8.4%6.9 $34.46
10/30/20204,760,000 shares $142.13 million -7.9%8.2%4 $29.86
10/15/20205,170,000 shares $167.66 million +12.6%9.0%1.8 $32.43
9/30/20204,590,000 shares $129.94 million No Change7.9%1.6 $28.31
9/15/20204,590,000 shares $125.40 million -12.4%7.9%1.6 $27.32
8/31/20205,240,000 shares $138.81 million -25.5%9.1%1.8 $26.49
🚀 Tap into this explosive trade opportunity asap (Ad)

I learned about these explosive stocks during my two decades on Wall Street… And used them to help grow my old hedge fund from just a few million to over $700 million dollars*. So it’s safe to say… these bad boys work. What’s the secret behind these special trades? Well, right now, I’m going public with the unique strategy behind these “Calendar Stocks”…

Go here to see how you can exploit my next “Calendar Stock”.
8/14/20207,030,000 shares $191.64 million -21.2%13.2%2.5 $27.26
7/31/20208,920,000 shares $33.36 million +16.3%19.6%3.9 $3.74
7/15/20207,670,000 shares $31.68 million +3.1%17.7%11.8 $4.13
6/30/20207,440,000 shares $34.74 million +6.1%17.1%13.2 $4.67
6/15/20207,010,000 shares $30.70 million +4.0%16.1%16 $4.38
5/29/20206,740,000 shares $37.00 million +8.7%15.7%16.9 $5.49
5/15/20206,200,000 shares $28.52 million +10.9%14.5%16.8 $4.60
4/30/20205,590,000 shares $21.86 million +9.6%13.1%17.4 $3.91
4/15/20205,100,000 shares $18.87 million +6.7%12.2%19.3 $3.70
3/31/20204,780,000 shares $17.35 million -7.9%11.4%18.8 $3.63
3/13/20205,187,600 shares $17.59 million +4.8%12.5%19.3 $3.39
2/28/20204,950,000 shares $16.83 million +2.3%12.0%22.9 $3.40
2/14/20204,840,000 shares $14.62 million +1.9%11.9%22.9 $3.02
1/31/20204,750,000 shares $16.96 million +3.3%11.6%22.7 $3.57
1/15/20204,600,000 shares $16.74 million +15.9%11.2%21.8 $3.64
12/31/20193,970,000 shares $12.43 million +6.7%9.7%19.8 $3.13
8/15/20194,911,000 shares $19.10 million +3.5%23.7%8.6 $3.89

MCRB Short Interest - Frequently Asked Questions

What is Seres Therapeutics' current short interest?

Short interest is the volume of Seres Therapeutics shares that have been sold short but have not yet been covered or closed out. As of May 15th, traders have sold 22,740,000 shares of MCRB short. Learn More on Seres Therapeutics' current short interest.

What is a good short interest ratio for Seres Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MCRB shares currently have a short interest ratio of 5.0. Learn More on Seres Therapeutics's short interest ratio.

Is Seres Therapeutics' short interest increasing or decreasing?

Seres Therapeutics saw a increase in short interest in May. As of May 15th, there was short interest totaling 22,740,000 shares, an increase of 6.0% from the previous total of 21,460,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Seres Therapeutics' short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Seres Therapeutics: FibroGen, Inc. (7.42%), Nektar Therapeutics (1.49%), Avid Bioservices, Inc. (18.68%), Cryoport, Inc. (8.54%), Y-mAbs Therapeutics, Inc. (9.85%), SIGA Technologies, Inc. (12.36%), Altimmune, Inc. (32.52%), Heron Therapeutics, Inc. (20.09%), COMPASS Pathways plc (5.00%), Entrada Therapeutics, Inc. (9.08%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks.

What does it mean to sell short Seres Therapeutics stock?

Short selling MCRB is an investing strategy that aims to generate trading profit from Seres Therapeutics as its price is falling. MCRB shares are trading up $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Seres Therapeutics?

A short squeeze for Seres Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of MCRB, which in turn drives the price of the stock up even further.

How often is Seres Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MCRB, twice per month. The most recent reporting period available is May, 15 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:MCRB) was last updated on 5/29/2024 by MarketBeat.com Staff

From Our Partners